News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...

Recent Postings



Dendreon (DNDN) Galena (GALE) Bristol-Myers Squibb (BMY) MODERNA Onyx (ONXX) AstraZeneca (AZN) Prolor Biotech (PBTH) KITE (KITE) Micromet (MITI) Agenus (AGEN) Merck (MRK) INNOVIVA (INVA) Amgen (AMGN) AERIE PHARMACEUTICALS Inovio (INO) Mirati Therapeutics (MRTX) Human Genome Sciences (HGSI) Spike Therapeutics (ONCE) Velcade (bortezomib) Jazz Pharmaceuticals (JAZZ) GUARDIAN HEALTH Array Pharmaceuticals (ARRY) Gilead (GILD) Valeant Pharmaceuticals International (VRX) Ionis (IONS) ADVENTRIX (ANX) Multiple Myeloma PTC Therapeutics (PTCT) Sarepta (SRPT) Incyte (INCY) Alder Biopharmaceuticals (ALDR) Genentech Editas (EDIT) ARGOS (ARGS) Sanofi (SNA) Herceptin galapagos (GLPG) Seattle Genetics (SGEN) SYNTA (SNTA) BIOMARIN (BMRN) TOKAI (TKAOI) Adaptimmune (ADAP) VANDA (VNDA) Pluristem (PSTI) Advaxis (ADXS) OSI (OSIP) Abbott Laboratories (ABT) Ridaforolimus CompuGen (CGEN) Intercept (ICPT) ISIS (ISIS) IDERA (IDRA) Ziofpharm (ZIOP) Benlysta (belimumab) Intermune (ITMN) Alnylam (ALNY) Sequenom (SQNM) Biocryst (BCRX) Auspex (ASPX) AGOS (ARGS) Vertex (VRTX) Elan (ELN) ABBVIE (ABBV) Intrexon (XON) JUNO (JUNO) Vitae Pharmaceuticals (VTAE) Sanofi-Aventis (SAN) HALOZYME (HALO) Revlimid (lenolidamide) Bellicum (BLCM) ACADIA (ACAD) Sanofi (SNY) Aimmune Therapeutics (AIMT) SUNESIS PHARMACEUTICALS (SNSS) ZALTRAP™ SERES THERAPEUTICS (MCRB) Ariad (ARIA) ARCA (ABIO) Exelixis (EXEL) Anadys (ANDS) GlaxoSmithKline (GSK) Endometrial Cancer NANTKWEST (NK) ImmunoGen (IMGN) Roche (ROCHE) Biogen Idec (BIIB) Dynavax (DVAX) Xoma (XOMA) Roche (RHHBY) Rapamune Idenix (IDIX) NEKTAR (NKTR)) Agenus (AGEN Prosensa (RNA) Sangamo (SGMO) Telaprevir Anacor (ANAC) C4 Therapeutics RenenxBio (RGNX) Tysabri Cytokinetics (CYTK) Regeneron (REGN) Theravance Bio Pharma (TBPH) NOVOCURE (NVCR) Illumina (ILMN) Theravance (THRX) REGULUS (RGLS) Trastuzumab-DM1 Global Cell Therapeutics (GBT) Human Longevity (HLI) Zerenex KERYX (KERX)